Launch week offerEnds in00h00m00s

annual Promonthly Pro

Ying Tan

Peking University

China

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (1)

Junyu Xiao

Principal Investigator

Peking University

CHINA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ying Tan

Research Interests

Make your next move.

Articles (20)

Complement C3 recognition by C3 convertases

Neutrophil Extracellular Traps Aggravate Injury in Complement-Mediated Thrombotic Microangiopathy

CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy

Immunological Characteristics of Chinese Adult Patients with Anti-Complement Factor H Autoantibodies-Associated Complement-Mediated Thrombotic Microangiopathy

The Complement System in Membranous Nephropathy: Pathogenesis and Targeted Therapies

Bispecific MASP-2/3 antibody provides superior renoprotection over monotherapy in pristane-induced lupus nephritis

B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single-arm cohort study of telitacicept

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy

Complement system activation: bridging physiology, pathophysiology, and therapy

Differential contributions of the C5b-9 and C5a/C5aR pathways to microvascular and macrovascular thrombosis in complement-mediated thrombotic microangiopathy patients

Kidney thrombotic microangiopathy with concurrent monoclonal gammopathy

A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy

ADAMTS7-Mediated Complement Factor H Degradation Potentiates Complement Activation to Contributing to Renal Injuries

Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis

B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis

CIDP/autoimmune nodopathies with nephropathy: a case series study

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy

Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis

Efficacy and safety of belimumab in lupus nephritis patients: a real-world observational study in China

Glomerular mTORC1 activation was associated with podocytes to endothelial cells communication in lupus nephritis

Collaborators (1)

Junyu Xiao

Make your next move.